论文部分内容阅读
Aim:In this study,we would like to determine associations between β2-Adrenergic Receptor(β2AR)polymorphisms at codon 16 and 27 and the response to short acting β2-agonist during asthmatic exacerbation.Methods:This was a prospective cross-sectional study of one year duration.One hundred and thirty two asthmatic patients were recruited.Five mls of venous blood was taken for DNA extraction and then genotyped for the β2AR polymorphisms using multiplex PCR.Patient’s clinical responses to β2-agonist nebulization were then compared to their genotype to determine the association.Results:We found that there was no association between β2AR polymorphisms at both codon 16 and 27 with response towards short acting β2-agonist,P=0.315 and P=0.706 respectively.Conclusion:We suggested that β2AR polymorphisms at both codon 16 and 27 had no influent on the response to short acting β2-agonist.
Aim: In this study, we would like to determine associations between β2-Adrenergic Receptor (β2AR) polymorphisms at codon 16 and 27 and the response to short acting β2-agonist during asthmatic exacerbation. Methods: This was a prospective cross-sectional study of One year duration. One hundred and thirty two asthmatic patients were recruited. Fives mls of venous blood was taken for DNA extraction and then genotyped for the β2AR polymorphisms using multiplex PCR. Part of’s clinical responses to β2-agonist nebulization were then compared to their genotype to determine the association. Results: We found that there was no association between β2AR polymorphisms at both codon 16 and 27 with response towards short acting β2-agonist, P = 0.315 and P = 0.706 respectively. Conclusion: We suggested that β2AR polymorphisms at both codon 16 and 27 had no influent on the response to short acting β2-agonist.